|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.050 USD | -1.63% |
|
+0.67% | -9.54% |
| 05-13 | Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-12 | Harvard Bioscience, Inc., Q1 2026 Earnings Call, May 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.63% | +0.67% | +2.89% | +24.23% | -9.54% | +36.32% | -88.98% | -92.74% | -78.85% | 27.74M | |
| +2.39% | +9.37% | +4.23% | +4.44% | -11.41% | +26.60% | -1.61% | +1.76% | +247.41% | 186B | |
| +1.18% | -0.20% | -5.24% | -12.71% | -28.95% | -25.95% | +17.68% | +31.26% | +447.53% | 141B | |
| +1.70% | +8.24% | +6.05% | +2.17% | -15.38% | -1.93% | -19.28% | -27.81% | +91.80% | 135B | |
| +0.89% | -5.57% | -10.87% | -31.38% | -54.84% | -59.91% | -20.39% | +0.70% | +84.25% | 63.44B | |
| +1.69% | +5.80% | +6.38% | +14.87% | +7.91% | +17.62% | -2.48% | -11.18% | +176.72% | 52.09B | |
| +0.82% | -0.12% | -1.26% | -5.01% | -23.24% | -26.73% | -33.51% | -33.28% | - | 43.6B | |
| +0.42% | +5.31% | -1.58% | +17.03% | -1.97% | +13.03% | +10.93% | -9.76% | +200.70% | 37.52B | |
| +0.82% | +5.86% | -1.42% | +26.97% | -0.45% | +8.33% | +41.87% | +9.41% | +168.84% | 36.82B | |
| +1.33% | +1.79% | +4.04% | -8.88% | -20.92% | -12.43% | -20.16% | - | - | 29.12B | |
| +3.19% | +5.14% | +5.53% | -10.42% | -16.51% | -22.05% | -7.96% | -18.42% | +218.05% | 28.14B | |
| +4.58% | +11.50% | +12.84% | +49.19% | +40.20% | +92.74% | -1.92% | -61.14% | +30.99% | 26.6B | |
| +0.84% | +2.35% | +4.77% | +2.66% | +3.10% | +17.39% | +25.09% | -38.06% | +17.93% | 25.84B | |
| +4.32% | +1.66% | -6.67% | -13.94% | -25.60% | -36.95% | -52.74% | -70.48% | - | 24.18B | |
| +0.48% | -.--% | -.--% | +0.56% | +2.04% | +16.65% | -6.13% | +13.92% | +119.68% | 16.97B | |
| +1.42% | +12.95% | +7.93% | +28.80% | +16.63% | +16.67% | -5.01% | -26.92% | +115.26% | 12.41B | |
| -3.12% | +0.49% | -7.81% | +10.58% | -17.06% | -4.02% | -27.36% | -25.45% | +73.49% | 11.1B | |
| +0.76% | +10.03% | +2.97% | +67.88% | +28.72% | +47.18% | -17.97% | -20.19% | +166.67% | 9.16B | |
| -1.16% | +8.20% | -7.16% | -15.09% | -19.13% | +31.67% | - | - | - | 4.2B | |
| +0.85% | +2.24% | -12.73% | +56.46% | - | - | - | - | - | 3.51B | |
| Average | +1.03% | +3.71% | +0.14% | +10.42% | -7.71% | +7.06% | -11.66% | -22.26% | +138.70% | 44.34B | |
| Weighted average by Cap. | +1.45% | +3.90% | +1.00% | +1.42% | -14.44% | -0.18% | -3.95% | -7.56% | +208.45% |
- Stock Market
- Stocks
- HBIO Stock
- Sector Harvard Bioscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
